275 related articles for article (PubMed ID: 19069108)
1. [Oral antifungal agents].
Tarumoto N; Maesaki S
Nihon Rinsho; 2008 Dec; 66(12):2373-7. PubMed ID: 19069108
[TBL] [Abstract][Full Text] [Related]
2. [Choice and use of antifungal drugs].
Dupont B
Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
[TBL] [Abstract][Full Text] [Related]
3. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Niki Y
Jpn J Antibiot; 2000 Feb; 53(2):108-31; discussion 131-3. PubMed ID: 10896538
[No Abstract] [Full Text] [Related]
6. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
7. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
8. Current drug therapy of systemic mycoses: a review.
Yonga G
East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014
[TBL] [Abstract][Full Text] [Related]
9. Systemic antifungal drugs.
Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
[No Abstract] [Full Text] [Related]
10. A brief review of antifungal therapy for deep fungal infection.
Muller RJ
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Fehér J; Lengyel G
Orv Hetil; 2003 Aug; 144(34):1677-82. PubMed ID: 14528841
[TBL] [Abstract][Full Text] [Related]
12. [Commonly used antifungal agents in the treatment of systemic mycoses].
Berenguer Berenguer J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
[No Abstract] [Full Text] [Related]
13. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
14. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacies of antifungal injections].
Fujii Y; Inase N; Yoshizawa Y
Nihon Rinsho; 2008 Dec; 66(12):2378-83. PubMed ID: 19069109
[TBL] [Abstract][Full Text] [Related]
16. Antifungal agents used for deep-seated mycotic infections.
Terrell CL; Hermans PE
Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
18. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
Silling G; Fegeler W; Roos N; Essink M; Büchner T
Mycoses; 1999; 42 Suppl 2():101-4. PubMed ID: 10865914
[TBL] [Abstract][Full Text] [Related]
19. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
